|
Volumn 90, Issue 4, 2002, Pages 488-494
|
Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: Inhibitory potential depends on type of injury and leukocytes targeted
|
Author keywords
Leukocytes; Primates; Stents
|
Indexed keywords
CD18 ANTIGEN;
CHEMOKINE RECEPTOR CCR2;
IMMUNOGLOBULIN G2A;
INTEGRIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY 1D9;
MONOCLONAL ANTIBODY IB4;
MONOCYTE CHEMOTACTIC PROTEIN 1;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTERY INTIMA PROLIFERATION;
ARTICLE;
BALLOON CATHETER;
CORONARY ARTERY DISEASE;
CORONARY STENT;
EXPERIMENTAL MODEL;
IMMUNOCYTOCHEMISTRY;
LEUKOCYTE;
MACACA;
MALE;
MONOCYTE;
NEUTROPHIL;
NONHUMAN;
PRIMATE;
PRIORITY JOURNAL;
RESTENOSIS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD18;
BALLOON DILATATION;
BLOOD VESSEL PROSTHESIS IMPLANTATION;
DISEASE PROGRESSION;
GRAFT OCCLUSION, VASCULAR;
HYPERPLASIA;
ILIAC ARTERY;
IMMUNOHISTOCHEMISTRY;
LEUKOCYTES;
MACACA FASCICULARIS;
MACROPHAGES;
MALE;
MONOCYTES;
NEUTROPHILS;
RECEPTORS, CHEMOKINE;
STENTS;
TUNICA INTIMA;
VASCULAR PATENCY;
|
EID: 0037040835
PISSN: 00097330
EISSN: None
Source Type: Journal
DOI: 10.1161/hh0402.105956 Document Type: Article |
Times cited : (117)
|
References (35)
|